---
input_text: 'Treating neuromuscular diseases: unveiling gene therapy breakthroughs
  and pioneering future applications. In this review, we highlight recent advancements
  in adeno-associated virus (AAV)-based gene therapy for genetic neuromuscular diseases
  (NMDs), focusing on spinal muscular atrophy (SMA) and Duchenne muscular dystrophy
  (DMD). We discuss the current FDA-approved gene therapies for NMDs and provide updates
  on preclinical studies that demonstrate the potential of various AAV-based gene
  therapies to reduce SMA severity and serve as effective treatments for DMD. Additionally,
  we explore the transformative impact of CRISPR/Cas9 technology on the future of
  gene therapy for NMDs. Despite these encouraging developments, further research
  is required to identify robust biomarkers that can guide treatment decisions and
  predict outcomes. Overall, these pioneering advancements in AAV-based gene therapy
  lay the groundwork for future efforts aimed at curing genetic NMDs and offer a roadmap
  for developing gene therapies for other neurodegenerative diseases.'
raw_completion_output: |-
  primary_disease: genetic neuromuscular diseases (NMDs)
  medical_actions: gene therapy; FDA-approved gene therapies; CRISPR/Cas9 technology
  symptoms: SMA severity
  chemicals: adeno-associated virus (AAV)
  action_annotation_relationships: gene therapy (with adeno-associated virus (AAV)) TREATS SMA severity IN genetic neuromuscular diseases (NMDs); FDA-approved gene therapies PREVENTS SMA severity IN genetic neuromuscular diseases (NMDs); CRISPR/Cas9 technology PREVENTS SMA severity IN genetic neuromuscular diseases (NMDs)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  CRISPR/Cas9 technology PREVENTS SMA severity IN genetic neuromuscular diseases (NMDs)

  ===

extracted_object:
  primary_disease: genetic neuromuscular diseases (NMDs)
  medical_actions:
    - MAXO:0001001
    - FDA-approved gene therapies
    - CRISPR/Cas9 technology
  symptoms:
    - SMA severity
  chemicals:
    - adeno-associated virus (AAV)
  action_annotation_relationships:
    - subject: MAXO:0001001
      predicate: TREATS
      object: SMA severity
      qualifier: genetic neuromuscular diseases (NMDs)
      subject_qualifier: with adeno-associated virus (AAV)
      subject_extension: adeno-associated virus (AAV)
    - subject: FDA-approved gene therapies
      predicate: PREVENTS
      object: SMA severity
      qualifier: genetic neuromuscular diseases
      subject_extension: gene therapies
    - subject: CRISPR/Cas9 technology
      predicate: PREVENTS
      object: SMA severity
      qualifier: genetic neuromuscular diseases
      subject_extension: CRISPR/Cas9 technology
named_entities:
  - id: MONDO:0001516
    label: Spinal Muscular Atrophy
  - id: HP:0002650
    label: Scoliosis
  - id: HP:0007269
    label: Spinal Muscular Atrophy
  - id: MONDO:0005392
    label: scoliosis
  - id: HP:0003323
    label: Progressive muscle weakness
  - id: CHEBI:76720
    label: Antisense oligonucleotides
  - id: MAXO:0001001
    label: Gene therapy
  - id: MONDO:0005015
    label: Diabetes
  - id: HP:0001635
    label: heart failure
  - id: HP:0001324
    label: muscle weakness
  - id: HP:0003202
    label: muscle atrophy
  - id: CHEBI:16991
    label: DNA
  - id: CHEBI:33697
    label: RNA
  - id: MONDO:0019079
    label: spinal muscular atrophy (SMA)
  - id: HP:0006959
    label: <spinal muscular atrophy (SMA)>
  - id: MONDO:0002602
    label: CNS disorders
  - id: HP:0002011
    label: central nervous system diseases
  - id: MAXO:0000506
    label: Noninvasive ventilation (NIV)
  - id: MONDO:0019056
    label: Neuromuscular diseases
  - id: CHEBI:35341
    label: steroid
  - id: MAXO:0000011
    label: Physiotherapy
  - id: MAXO:0000458
    label: Hydrotherapy
  - id: HP:0012393
    label: Allergic reaction
  - id: MONDO:0005359
    label: Drug-induced liver injury
  - id: HP:0006554
    label: Acute liver failure
  - id: CHEBI:50858
    label: Corticosteroids
  - id: HP:0000556
    label: Retinal dystrophy
  - id: HP:0003125
    label: Hemophilia A
  - id: HP:0010535
    label: sleep disordered breathing (SDB)
  - id: MONDO:0009669
    label: Spinal muscular atrophy type 1
  - id: MAXO:0001346
    label: Gastrostomy
  - id: MAXO:0000021
    label: Palliative care
  - id: HP:0002093
    label: Respiratory insufficiency
  - id: HP:0002098
    label: Respiratory distress
  - id: HP:0008443
    label: Spinal deformities
  - id: MONDO:0010679
    label: Duchenne muscular dystrophy
  - id: HP:0000708
    label: psychiatric disorders
  - id: HP:0025406
    label: weakness
  - id: MONDO:0010526
    label: Farber disease (FD); spinal muscular atrophy with progressive myoclonic
      epilepsy (SMA-PME)
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation (HSCT)
  - id: HP:0000083
    label: kidney impairment
  - id: MONDO:0009218
    label: Farber disease
  - id: MONDO:0008045
    label: spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME)
  - id: CHEBI:35705
    label: immunosuppressant
  - id: HP:0001873
    label: Thrombocytopenia
  - id: MAXO:0000915
    label: polysomnography
  - id: HP:0002205
    label: recurrent respiratory infections
  - id: MONDO:0000001
    label: disease
  - id: HP:0011968
    label: Feeding difficulties
  - id: HP:0001270
    label: Motor delay
  - id: HP:0002380
    label: Fasciculation
  - id: HP:0012378
    label: fatigue
  - id: CHEBI:33330
    label: SCS
  - id: CHEBI:33699
    label: messenger RNAs (mRNAs)
  - id: MAXO:0000504
    label: Tracheostomy
